Results 41 to 50 of about 334,470 (291)

Anticoagulants [PDF]

Journal of Pharmacy and Pharmacology, 1949
Abstract The processes that underly the clotting of blood are still far from adequately understood, in spite of the many facts uncovered by generations of patient investigators. The classical scheme associated with the name of Morawitz1, although neither complete nor universally accepted, is still useful as a summary of the main events ...
openaire   +2 more sources

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation

Clinical and applied thrombosis/hemostasis, 2020
The novel coronavirus infection (COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can lead to severe manifestations such as adult respiratory syndrome, sepsis, coagulopathy, and death
Wolfgang A. Miesbach, M. Makris
semanticscholar   +1 more source

Micro-computed tomography for the quantification of blocked fibers in hemodialyzers [PDF]

, 2018
A novel technique based on micro-CT scanning is developed to quantify coagulation in fibers of hemodialyzers. This objectivation is needed to allow accurate assessment of thrombogenicity of dialyzers used during hemodialysis, for example when comparing ...
Boone, Matthieu, Dhondt, Annemieke, Dierick, Manuel, Eloot, Sunny, Van Biesen, Wim, Vanommeslaeghe, Floris   +5 more
core   +2 more sources

Cardioverting acute atrial fibrillation and the risk of thromboembolism: not all patients are created equal [PDF]

, 2017
Current guidelines support the well-established clinical practice that patients who present with atrial fibrillation (AF) of less than 48 hours duration should be considered for cardioversion, even in the absence of pre-existing anticoagulation. However,
Rankin, Alastair J., Rankin, Stephen H.
core   +1 more source

Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry

Open Heart, 2023
Objective There is a substantial incidence of stroke in patients with atrial fibrillation (AF) not receiving anticoagulation. The reasons for not receiving anticoagulation are generally attributed to clinician’s choice, however, a proportion of AF ...
Ajay K Kakkar, Keith A A Fox, Sylvia Haas, Saverio Virdone, Jean-Pierre Bassand, Karen S Pieper, Alexander G G Turpie, Gloria Kayani, Seil Oh, Jörn Nielsen, Frank Cools, John Camm, Marianne Brodmann, Patricia Apenteng, Antonio C P Barretto   +14 more
doaj   +1 more source

Anticoagulants [PDF]

British Medical Bulletin, 2000
Anticoagulation is a treatment with significant and life threatening complications requiring that the balance of risk and benefit be individually assessed in each patient. The risks are greater in the elderly and those with hypertension, falls and gastrointestinal disease.
openaire   +2 more sources

Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.

New England Journal of Medicine, 2020
BACKGROUND The roles of anticoagulation alone or with an antiplatelet agent after transcatheter aortic-valve implantation (TAVI) have not been well studied.
V. Nijenhuis, J. Brouwer, R. Delewi, R. Hermanides, W. Holvoet, C. Dubois, P. Frambach, B. de Bruyne, G. V. van Houwelingen, J. van der Heyden, P. Toušek, F. van der Kley, I. Buysschaert, C. Schotborgh, B. Ferdinande, P. van der Harst, J. Roosen, J. Peper, Frederick W F Thielen, L. Veenstra, D. R. Chan Pin Yin, M. Swaans, B. Rensing, A. W. van ’t Hof, L. Timmers, J. Kelder, P. Stella, J. Baan, J. T. ten Berg   +28 more
semanticscholar   +1 more source

Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum

Journal of Thrombosis and Thrombolysis, 2022
Thromboembolism is a common and deadly consequence of COVID-19 infection for hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and early observational reports, expert consensus and guidance documents have strongly ...
G. Barnes, Allison E. Burnett, Arthur L. Allen, J. Ansell, Marilyn Blumenstein, N. Clark, M. Crowther, William E. Dager, S. Deitelzweig, S. Ellsworth, David A. Garcia, S. Kaatz, L. Raffini, A. Rajasekhar, A. V. Beek, Tracy Minichiello   +15 more
semanticscholar   +1 more source

Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review [PDF]

, 2016
Objective:Atrial Fibrillation (AF) is associated with dementia. If AF-related cognitive decline is driven by cerebral embolic events, thromboprophylaxis may impact on this.
Lane, Deirdre A., Moffitt, Peter, O'Connell, Janice, Park, Helen, Quinn, Terence J.   +4 more
core   +2 more sources

Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2020
Importance Although current guidelines suggest the use of regional citrate anticoagulation (which involves the addition of a citrate solution to the blood before the filter of the extracorporeal dialysis circuit) as first-line treatment for continuous ...
A. Zarbock, M. Küllmar, D. Kindgen-Milles, C. Wempe, J. Gerss, T. Brandenburger, T. Dimski, B. Tyczynski, M. Jahn, Nils Mülling, M. Mehrländer, P. Rosenberger, G. Marx, T. Simon, U. Jaschinski, P. Deetjen, C. Putensen, J. Schewe, S. Kluge, D. Jarczak, T. Slowinski, M. Bodenstein, P. Meybohm, S. Wirtz, O. Moerer, A. Kortgen, P. Simon, S. Bagshaw, J. Kellum, M. Meersch   +29 more
semanticscholar   +1 more source